Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074889 | SCV001240493 | uncertain significance | Retinal dystrophy | 2019-08-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002554733 | SCV002974577 | uncertain significance | not provided | 2022-03-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 866676). This variant has not been reported in the literature in individuals affected with SNRNP200-related conditions. This variant is present in population databases (rs762289712, gnomAD 0.002%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 246 of the SNRNP200 protein (p.Ala246Val). |
Ambry Genetics | RCV004031185 | SCV004954399 | uncertain significance | Inborn genetic diseases | 2023-12-14 | criteria provided, single submitter | clinical testing | The c.737C>T (p.A246V) alteration is located in exon 7 (coding exon 7) of the SNRNP200 gene. This alteration results from a C to T substitution at nucleotide position 737, causing the alanine (A) at amino acid position 246 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |